Wegovy 0.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7WVF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $161,761
Award facts
- Contract value 100% obligated
- $161,760.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $161,761 to AmerisourceBergen Drug Corp for Wegovy 0.5 mg/0.5 mL pens. This firm fixed-price contract, which carries an ultimate completion date of January 7, 2026, represents a non-set-aside, competitively awarded procurement. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle valued through December 31, 2031, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, brings substantial experience fulfilling DLA supply chain requirements across diverse therapeutic domains. The delivery order for Wegovy, a diabetes and weight management medication, aligns with the company's established portfolio supplying prescription medications to military treatment facilities, the Defense Health Agency, and other federal healthcare systems. As a subsidiary of Cencora, Inc., AmerisourceBergen continues to serve as a primary vendor for the DLA's pharmaceutical supply needs, leveraging its extensive distribution network and product availability to support government healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F7WVF?
SPE2DR26F7WVF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F7WVF worth?
The government has obligated $161,761 on SPE2DR26F7WVF.
Is contract SPE2DR26F7WVF an order under another contract?
Yes. SPE2DR26F7WVF is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WVF competed?
The extent of competition for SPE2DR26F7WVF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award